Coexistence of impairment of endothelium-derived nitric oxide and platelet-derived nitric oxide in patients with coronary risk factors - PubMed (original) (raw)
Clinical Trial
doi: 10.1253/circj.66.837.
Affiliations
- PMID: 12224822
- DOI: 10.1253/circj.66.837
Free article
Clinical Trial
Coexistence of impairment of endothelium-derived nitric oxide and platelet-derived nitric oxide in patients with coronary risk factors
Atsushi Katoh et al. Circ J. 2002 Sep.
Free article
Abstract
Impairment of endothelium-derived nitric oxide (EDNO) has been demonstrated in patients with coronary risk factors in some studies, as well as impaired platelet-derived nitric oxide (PDNO) in other studies. However, no study has examined whether these impairments coexist. In 24 patients with coronary risk factors, femoral vascular endothelial function was assessed with acetylcholine (ACh: 50, 100, 200 and 400 microg/min) and endothelium-independent vascular function with nitroglycerin (NTG; 50, 100, 200 microg/min) using a Doppler flow-wire technique, as well as ADP (5 micromol/L)-induced PDNO release with an NO-specific electrode. The ACh-mediated percent change in femoral vascular resistance index (% change of FVRI) and PDNO release had a significant correlation with the number of risk factors. The ACh-mediated % change of FVRI, but not that with NTG, significantly correlated with the PDNO release. Both EDNO and PDNO bioactivities are impaired in patients with coronary risk factors and there is a common mechanism.
Similar articles
- Platelet-derived nitric oxide and coronary risk factors.
Ikeda H, Takajo Y, Murohara T, Ichiki K, Adachi H, Haramaki N, Katoh A, Imaizumi T. Ikeda H, et al. Hypertension. 2000 Apr;35(4):904-7. doi: 10.1161/01.hyp.35.4.904. Hypertension. 2000. PMID: 10775559 - Glutathione reverses endothelial dysfunction and improves nitric oxide bioavailability.
Prasad A, Andrews NP, Padder FA, Husain M, Quyyumi AA. Prasad A, et al. J Am Coll Cardiol. 1999 Aug;34(2):507-14. doi: 10.1016/s0735-1097(99)00216-8. J Am Coll Cardiol. 1999. PMID: 10440166 - Impairment of coronary blood flow regulation by endothelium-derived nitric oxide in dogs with alloxan-induced diabetes.
Matsunaga T, Okumura K, Ishizaka H, Tsunoda R, Tayama S, Tabuchi T, Yasue H. Matsunaga T, et al. J Cardiovasc Pharmacol. 1996 Jul;28(1):60-7. doi: 10.1097/00005344-199607000-00010. J Cardiovasc Pharmacol. 1996. PMID: 8797137 - Coronary vasomotor responses: role of endothelium and nitrovasodilators.
Bassenge E. Bassenge E. Cardiovasc Drugs Ther. 1994 Aug;8(4):601-10. doi: 10.1007/BF00877414. Cardiovasc Drugs Ther. 1994. PMID: 7531489 Review. - Endothelium-derived nitric oxide: pharmacology and relationship to the actions of organic nitrate esters.
Ignarro LJ. Ignarro LJ. Pharm Res. 1989 Aug;6(8):651-9. doi: 10.1023/a:1015926119947. Pharm Res. 1989. PMID: 2510139 Review.
Cited by
- Water-soluble tomato concentrate modulates shear-induced platelet aggregation and blood flow in vitro and in vivo.
Liu L, Xiao S, Wang Y, Wang Y, Liu L, Sun Z, Zhang Q, Yin X, Liao F, You Y, Zhang X. Liu L, et al. Front Nutr. 2022 Sep 2;9:961301. doi: 10.3389/fnut.2022.961301. eCollection 2022. Front Nutr. 2022. PMID: 36118749 Free PMC article. - The Human Microcirculation: Regulation of Flow and Beyond.
Gutterman DD, Chabowski DS, Kadlec AO, Durand MJ, Freed JK, Ait-Aissa K, Beyer AM. Gutterman DD, et al. Circ Res. 2016 Jan 8;118(1):157-72. doi: 10.1161/CIRCRESAHA.115.305364. Circ Res. 2016. PMID: 26837746 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources